Description

Methyl 3-(3-Methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylate is a high-purity, advanced pharmaceutical intermediate of significant interest in modern organic synthesis. This compound serves as a critical building block for the development of novel active pharmaceutical ingredients (APIs) and other fine chemicals. It is primarily sought by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical industries for its unique heterocyclic structure, which is integral to creating molecules with targeted biological activity.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel quinazolinone-based drug candidates, potentially for applications in oncology, neurology, and anti-inflammatory therapies.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its complex heterocyclic core for bioactivity.
• Chemical Synthesis Building Block: Employed in organic chemistry research for constructing complex molecular architectures due to its reactive carbonyl and ester functional groups.
• Material Science Research: Investigated as a potential monomer or additive for creating specialized polymers with unique thermal or optical properties.
• Biochemical Probe Development: Utilized in life sciences research to develop molecular probes for studying enzyme interactions and biological pathways.

Basic Information

Product Name	Methyl 3-(3-Methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylate
CAS No.	917889-27-1
Molecular Formula	C₁₇H₁₄N₂O₅
Molecular Weight	326.30 g/mol
Synonyms	7-Carbomethoxy-3-(3-methoxyphenyl)-2,4(1H,3H)-quinazolinedione; Methyl 3-(3-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylate; 3-(3-Methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylic acid methyl ester; Quinazoline-7-carboxylic acid, 1,2,3,4-tetrahydro-3-(3-methoxyphenyl)-2,4-dioxo-, methyl ester; CAS 917889-27-1
EINECS	Contact for details

Quality Control

Our production of Methyl 3-(3-Methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxylate adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. All materials are subjected to rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with each shipment to support your quality assurance and regulatory compliance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials such as strong oxidizing agents, strong bases, and strong acids. For long-term storage, consider storing under an inert atmosphere to maintain product integrity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.